Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What:�Shares of QIWI PLC (NASDAQ: QIWI ) fell more than 16% Monday amid broader market unrest as Russia invaded Ukraine.�
So what:�The Moscow Exchange's Micex index fell nearly 11% on the day, so its unsurprising U.S.-listed Russian stocks like QIWI suffered the fallout. Shares of the Russia-based payment services provider are also still up more than 12% after a rapid rise over the past month, which at least partially explains the severity of today's drop.
Now what:�QIWI is all set to announce fourth quarter results on March 12, when investors hope the company can reprise last quarter's better-than-expected performance. Even so, I remain hesitant to dive in today given the wider macrco uncertainties surrounding Russia's decision. Until the dust settles and the longer-term repercussions for Russia's economy become more clear, I'm perfectly happy watching QIWI from the sidelines.
Top 5 Long Term Companies For 2015: Theravance Inc.(THRX)
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:
- [By Sean Williams]
What: Shares of Theravance (NASDAQ: THRX ) , a biopharmaceutical company that focuses on central nervous system and respiratory disorders, leapt as much as 19% -- its second double-digit jump this week -- following a positive recommendation from the Food and Drug Administration's panel regarding COPD drug Breo Ellipta.
- [By Brian Pacampara]
What: Shares of biopharmaceutical company Theravance (NASDAQ: THRX ) climbed as high as 13% today after announcing plans to split into two companies, separating its drugs under development with GlaxoSmithKline from its other operations.
Top Up And Coming Stocks To Buy For 2014: LifeLock Inc (LOCK)
LifeLock, Inc., incorporated on April 12, 2005, is a provider of proactive identity theft protection services for consumers and identity risk assessment and fraud protection services for enterprises. It operates in two segments: consumer segment and an enterprise segment. In its consumer segment, the Company offer identity theft protection services to consumers on a monthly or annual subscription basis. In its enterprise segment, it offer identity risk assessment and fraud protection services to enterprise customers who pay the Company based on their monthly volume of transactions with it. It protects its consumer subscribers, whom it refers to as its members, by monitoring identity-related events, such as new account openings and credit-related applications. It also provides remediation services to its members in the event that an identity theft actually occurs. On March 14, 2012, the Company acquired ID Analytics, Inc. In December 2013, the Company announced that it has completed the acquisition of Lemon Inc.
Consumer Business
The Company protects its members by proactively monitoring identity-related events, such as new account openings and credit-related applications, which may present a risk of identity theft. If it detects that a member�� personally identifiable information is being used, the Company sends notifications and alerts, including proactive, near real-time, actionable alerts, to the member via text message, phone call, or e-mail through its LifeLock Identity Alert system that allows the member to confirm valid or unauthorized identity use.
Enterprise Business
The Company delivers on-demand identity risk assessment and authentication information about consumers to its enterprise customers in their daily transaction flows. Its enterprise customers utilize this information in real time to authenticate their customers, assess their risk profile, and enhance the enterprise�� decision making process on which to base account opening, le! nding, credit, and other risk-based decisions. By integrating its services into their business processes, its enterprise customers can reduce potential financial losses from identity fraud. Information generated from the transaction flow at its enterprise customers is transmitted back to its data repositories, which continually enhances the LifeLock ecosystem and helps strengthen the services the Company can provide to its customers in the future.
The Company competes with Experian, Equifax, TransUnion, Affinion, Early Warning Systems, Intersections and LexisNexis.
Advisors' Opinion:- [By Rick Munarriz]
LifeLock (NYSE: LOCK ) is the leading provider of identity theft monitoring for consumers. This may seem like a finicky model for a subscription service, but LifeLock has come through with 34 consecutive quarters of sequential growth in revenue and members.
- [By Jon C. Ogg]
LifeLock Inc. (NYSE: LOCK) has only been public for about 15 months. It is a high beta stock, trading at 55-times expected trailing earnings and almost 48-times expected 2014 earnings. The driving force here is that identity theft and organized global fraud against consumers is forcing everyone to buy identity protection services. Target was the worst recent news on this front, but there are literally dozens of other companies who have had data breaches on their millions of customers. LifeLock shares hit a new high of $20.83 on Friday and closed up 1.6% at $20.41 on the day. This one is up about 150% from its IPO in late 2012.
- [By John Udovich]
Small cap security and surveillance stocks OSI Systems, Inc (NASDAQ: OSIS), Vimicro International Corporation (NASDAQ: VIMC), Analogic Corporation (NASDAQ: ALOG), Lifelock Inc (NYSE: LOCK) and View Systems Inc (OTCBB: VSYM) have been producing a steady flow of news lately that investors might want to take a closer look at. After all, the whole security and surveillance industry is pretty vast as it would include everything from airport scanners to security cameras to software securing everyone�� personal or online data. With that in mind, here is a look at the latest news from important small cap security and surveillance stocks:
- [By Luke Jacobi]
LifeLock (NYSE: LOCK) was also down, falling 17.57 percent to $10.70 after the company announced Friday that it had halted its mobile wallet service, shocking the street.
Top Up And Coming Stocks To Buy For 2014: Perrigo Company PLC (PRGO)
Perrigo Company plc, incorporated on March 23, 1988, is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. The Company�� businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia, and distributes into dozens of other markets worldwide, including Canada, China and Latin America. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.
The Company operates through several wholly owned subsidiaries. In the United States, its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., PBM Products, LLC, PBM Nutritionals, LLC, Paddock Laboratories, LLC, Perrigo Diabetes Care, LLC (formerly CanAm Care, LLC), Sergeant's Pet Care Products, Inc. and Fidopharm, Inc. Outside the United States, its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Galpharm Healthcare Ltd., Orion Laboratories Pty Ltd and Rosemont Pharmaceuticals Ltd.
Consumer Healthcare
Perrigo Consumer Healthcare (CHC) operation includes the Company's United States, United Kingdom and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Perrigo CHC supplies more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as w! ell as vitamins, dietary supplements and nutritional drinks. Perrigo offers a range of products, such advertised brand products as Tylenol, Advil or One-A-Day. Tylenol has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.
Perrigo Nutritionals
Perrigo is a manufacturer of nutrition products for the store brand market. Nutrition products include infant formula, pediatric nutritionals and vitamins, minerals, and supplements. Acquired by Perrigo, Perrigo Nutritionals, formerly PBM Products, LLC, had introduced private-label, or store-brand infant formulas to the United States. Perrigo Nutritionals is the supplier of store-brand infant formulas and nutrition products. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world. Its pediatric nutritionals business extends its offerings to children well beyond infancy. Its baby cereals, toddler foods, and pediatric nutritional drinks are available as store brands at various retail locations throughout the United States and the international community. Perrigo manufactures a range of vitamins, minerals, and supplements, in every major segment of the business. Marketed under the store brand labels of the retailers in the food, drug, mass-merchandise and wholesale club channels, it manufactures over 395 formulas of dietary supplements. Its brands include Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex.
Rx Pharmaceuticals
The Company�� Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the United States market. Manufacturing operations are based in the United States and Israel. Perrigo's portfolio focuses on complex, high-barrier ophthalmological, topical foam and or! al liquid! formulations. Its products include Acetylcysteine Injection 200 mg/mL (6g/30mL), Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS, ACTIDOSE with SORBITOL, ACTIDOSE-AQUA, ASPIRIN SUPPOSITORIES USP, Bacitracin Ophthalmic Ointment USP, Belladonna and Opium Suppositories C-II, BENZOIN COMPOUND TINCTURE USP, Benzoyl Peroxide 10% Acne Medication Wash, CLOBETASOL PROPIONATE LOTION 0.05% and Docusate Sodium.
Active Pharmaceutical Ingredients
Primarily through the Company�� Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. It manufactures API at facilities in Israel, India and China. Perrigo API specializes in tailor-made research and process development of APIs and Finished Dosage Forms (FDFs).
Life Sciences
Through the Company�� Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with pharmaceutical companies. Its Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements. Products in life sciences segment include TYSABRI and ELND005. TYSABRI (natalizumab) is indicated for treatment of: Multiple Sclerosis: as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy; Crohn�� Disease (CD): Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn�� disease with e! vidence o! f inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of tumor necrosis factor-伪.
Other
Perrigo's Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses. Other pharmaceutical and medical diagnostic products are imported to Israel through exclusive agreements with pharmaceutical and diagnostics companies. This business is divided into two departments: Pharma-Israel and Tayco Diagnostics. Pharma-Israel operates in the Israeli market as a partner in the marketing, sales and distribution of Rx (dermatology, gastroenterology, blood products, CNS, urology and other fields), OTC, generics, branded generics, dermo-cosmetics and dietary supplements. Tayco, the diagnostics division of Perrigo-Israel Pharmaceuticals Ltd., specializes in marketing and sales of medical laboratory systems, reagents, accessories and consumables. It also markets self-monitoring medical devices for diagnosis and treatment of diabetes. The division operates throughout Israel to service the central laboratory, hospital, clinic, point of care and self-testing markets. Its activities in the medical and research fields in Israel cover all market segments: medical (private and public health services), research institutions and the biotech industry.
The Company competes with Dr. Reddy�� Laboratories, Ltd., Actavis Inc., Aaron Industries, Inc., Ohm Laboratories, Inc., PL Developments, LNK International, Inc., Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber), Danone Baby Nutrition, Bayer AG, Pfizer, Inc., Rexall Sundown, Inc., Apotex, Glenmark Generics Inc., Impax, Prasco, Sandoz, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, and Zydus Pharmaceuticals.
Advisors' Opinion:- [By Benjamin Shepherd]
When you have a run-of-the-mill headache or cold, you take an aspirin or an antihistamine which you most likely picked up off a shelf at your pharmacy. You don�� see a doctor, you don�� have to talk to the pharmacist and you definitely don�� need a prescription for an over-the-counter (OTC) medication, some of which you might even take on a daily basis.
According to a paper from the American College of Preventative Medicine released in 2011, more than $17 billion of OTC products were sold in 2010 and more than a third of American adults reported using OTC medication on a regular basis. A survey conducted in 1999 showed that nearly 20 percent of the population used an OTC pain medication in any given week.
While there is the risk that readily available medications may be misused, OTC products are commonly used because they allow fast and direct access to effective medication for a whole host of common ailments. They also have the added benefit of helping to reduce the pressure on our health care system by preventing needless doctor calls.
When you think of OTC medications many of the first to come to mind, such as Tylenol, Sudafed and Benadryl, are products made by Johnson & Johnson (NYSE: JNJ). But over the past decade ��especially since the turmoil of the Great Recession ��there has been a rise in ��eneric generics,��otherwise known as store brands.
Most OTC medications have been around for decades, in the case of aspirin more than a century, and as a result have virtually no patent protections. That means that competition in the space has always been fierce and most manufacturers invest heavily in building up brand reputation for effectiveness, making it a relatively low margin business to begin with.
The market has become even more competitive since retailers have realized that they can keep more money in their own pockets by contracting for the production of virtually identical products which can be sold un - [By Holly LaFon]
Perrigo (PRGO) is a global manufacturer of over-the-counter (OTC) store brand and generic prescription pharmaceuticals, infant formulas, nutritional products and active pharma ingredients. The company is the dominant player in the OTC drug market with the largest distribution network and broadest range of product offerings. The OTC store brands have increased their market share by about 1-2% annually at the expense of national name product given their superior value proposition to both the consumer and retailers. Perrigo has numerous growth drivers over the next few years including the continued penetration of OTC store brands and introduction of new product categories. The stock sells at a reasonable valuation, in our opinion, given the company's strong management team, financial returns and long-term growth prospects.
- [By Rich Duprey]
Investors going with health-care products maker Perrigo� (NYSE: PRGO ) �will receive a�quarterly cash dividend�of�$0.09 per share on June 18 to shareholders of record at the close of business on May 31 for the fiscal third quarter of 2013.
Top Up And Coming Stocks To Buy For 2014: China Unicom (CHU)
China Unicom (Hong Kong) Limited (Unicom), incorporated on February 8, 2000, is an integrated telecommunications operator in China providing mobile voice and value-added, fixed-line voice and fixed-line broadband, data communications and other telecommunications services to its customers. The Company operates in two business segments consisting of mobile services and fixed-line services. The Company is engaged in global system for mobile communications (GSM) and wideband code division multiple access (WCDMA) cellular business in 31 provinces, municipalities and autonomous regions in China, the provision of fixedline voice, broadband and other Internet-related services, information and communications technology services, business and data communications services, and other related telecommunication value-added businesses. As of 30 June 2011, Unicom Group held 57.81% of the shares in the Company through China United Network Communications Limited (A Share Company), China Unicom (BVI) Limited and China Netcom Group Corporation (BVI) Limited, and Telefonica Internacional S.A.U. held 9.01% of the shares in the Company.
Mobile Business
Unicom�� mobile business consists of GSM and third generation (3G) mobile business. As of December 31, 2010, the Company had a total of 167.43 million mobile subscribers. As of December 31, 2010, its total number of mobile subscribers included 167.43 million. Unicom operates the 3G business based on the WCDMA technology nationwide in China. As of December 31, 2010, the total number of its 3G subscribers included 14.06 million, and had 1.35 million wireless data card subscribers, 2.41 million mobile television (TV) subscribers and over seven million mobile reading subscribers. During the year ended December 31, 2010, the total 3G voice usage was 55.47 billion minutes and the average data usage per subscriber per month was 178M. GSM mobile business primarily consists of GSM voice business and value-added business.
The Company�� mobile ! voice business enables its subscribers to make and receive phone calls with a mobile handset at any point within the coverage area of its mobile telecommunications networks. Its mobile voice business includes local calls, domestic long distance calls, international long distance calls, intra-provincial roaming, inter-provincial roaming and international roaming. As of December 31, 2010, the Company�� total number of GSM mobile subscribers was 153.37 million. Unicom offers a range of GSM value-added services nationwide, including short message service (SMS), Cool Ringtone (a personalized ring-back tone service), mobile Internet and other wireless information services. During 2010, a total of 78.31 billion SMSs were transmitted by its GSM mobile subscribers. As of December 31, 2010, the Company had a total number of 67.26 million subscribers to its Cool Ringtone service. In addition, as of December 31, 2010, it had a total number of 55.81 million mobile Internet subscribers.
Fixed-Line Business
Unicom is a fixed-line broadband and communications operator in northern China. The Company offers a range of fixed-line services nationwide in China, including fixed-line broadband services and data communications services; fixed-line voice services, include local and long distance fixed-line voice services and value-added services, and other services. The Company is a provider of fixed-line broadband services in its fixed-line northern service region. Unicom is a provider of data communications services in its fixed-line northern service region. It offers managed data products, such as those based on digital data networks (DDN), frame relay, asynchronous transfer mode (ATM) and Internet protocol-virtual private network (IP-VPN). The Company also offers leased line products, including domestic and international leased circuits. Its customers for these services include government entities, large financial institutions and other domestic and multinational businesses, Internet service prov! iders and! other telecommunications operators.
As of December 31, 2010, the Company had established business cooperation relationships with more than 160 overseas operators to provide various international data communications products and services, such as international voice and data services. During 2010, it continued to offer full-scale data communications services to international operators and domestic and international corporate customers. The Company�� fixed-line voice services consist of local voice, domestic long distance, international long distance, value-added, interconnection and personal handyphone system (PHS) services. In addition to fixed-line telephone voice services, it offers a range of value-added services on its fixed-line networks. The Company�� fixed-line, value-added services include Personalized Ring and caller identification services. Personalized Ring services enable its fixed-line subscribers to personalize the ring-back tone for incoming calls. As of December 31, 2010, the number of its Personalized Ring subscribers reached 23.79 million.
Interconnection and Roaming Arrangements
The Company earns interconnection fees for terminating or transiting calls that originate from other domestic telecommunications operators��networks and pay interconnection fees to other operators for calls originating from its networks that are terminated on their networks. It earns and pays such fees in respect of mobile calls, local and domestic and international long distance calls and Internet services, except for the interconnection by fixed-line subscribers calling its mobile subscribers in the same region where no interconnection fee will be charged.
The Company provides roaming services, which allow its subscribers to access its mobile services while they are physically outside of their registered service area or in the coverage areas of other mobile networks in other countries and regions with which it has roaming arrangements. As of April 30! , 2011, U! nicom had roaming arrangements for GSM international voice and SMS services with 242 operators in 521 countries and regions; GPRS international inbound data services with 179 operators in 400 countries and regions and for international GPRS outbound data services with 164 operators in 357 countries and regions, and 3G services with 104 WCDMA operators in 245 countries and regions.
Mobile Networks
The Company�� mobile network consists of cell sites, which are physical locations, each equipped with a base station that houses transmitters, receivers and other equipment used to communicate through radio channels with subscribers��mobile handsets within the range of a cell; base station controllers, which connect to, and control, the base stations, and mobile switching centers, which control the base station controllers and the routing of telephone calls. Its mobile network also consists of a transmission network, which links the mobile switching centers, base station controllers, base stations and the public switched telephone network. It has deployed GSM and WCDMA mobile networks. The Company�� GSM mobile network mainly operates at 900 megahertz. It has also deployed GSM technology that operates at 1,800 megahertz in metropolitan areas to supplement the capacity of its existing mobile network. As of December 31, 2010, the Company had approximately 329,000 GSM base stations.
The Company competes with China Mobile and China Telecom.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top losers in the sector included China Unicom (Hong Kong) (NYSE: CHU), off 4.5 percent, and Black Box (NASDAQ: BBOX), down 3 percent.
Top Headline
The Boeing Company (NYSE: BA) reported better-than-expected first-quarter profit. Boeing's quarterly profit declined to $965 million, or $1.28 per share, from a year-ago profit of $1.11 billion, or $1.44 per share. Its adjusted earnings surged to $1.76 per share compared to $1.73 per share. Its revenue climbed to $20.47 billion versus $18.89 billion. However, analysts were projecting earnings of $1.57 per share on revenue of $20.24 billion. For the full year, Boeing expects adjusted earnings of $7.15 to $7.35 per share. - [By David Goldman]
Until now, Apple had sold the iPhone there through China Mobile's much-smaller competitors, China Unicom (CHU)and China Telecom (CHA), which have about 425 million subscribers between them.
- [By Jim Jubak]
In the longer run, China's move to 4G��rom the current homegrown 3G and 2G standards��ill lead to a huge increase in highly lucrative data-heavy traffic for China Mobile (CHL), China's biggest operator, with 740 million subscribers, and, to a lesser degree, for smaller rivals China Unicom (CHU) and China Telecom (CHA). But that growth in traffic will come only after China Mobile spends heavily��31 billion in 2014��o upgrade its network. That's about what China Mobile will spend in 2013, and a 50% increase in capital spending over its five-year average.
- [By Doug Young]
I've been writing about the VNO development for awhile now, as it's really quite exciting with the potential to instantly triple the number of telecoms service providers in the market from the current three to a new field of 8-9 operators. Equally important, most of those new operators, which would lease network capacity from the existing three telcos, are private sector firms. That means they should be much more nimble and innovative than the current monopoly of three big state-run companies, China Mobile, China Unicom (CHU) and China Telecom (CHA).
Top Up And Coming Stocks To Buy For 2014: Xerium Technologies Inc.(XRM)
Xerium Technologies, Inc. manufactures and supplies consumable products used in the production of paper clothing and roll covers primarily in North America, Europe, South America, and the Asia-Pacific. It operates in two segments, Clothing and Roll Covers. The Clothing segment provides various types of industrial textiles used on paper-making machines and other industrial applications. This segment offers forming fabrics, press felts, and dryer fabrics; and fabrics used in other industrial applications, such as pulp, steel, plastics, leather, and textiles manufacturing. The Roll Covers segment manufactures, refurbishes, and replaces roll covers for working rolls, including vacuum rolls and press rolls; calendar rolls; and coater rolls that are used on paper-making machines. This segment also refurbishes previously installed roll covers; provides mechanical maintenance and repair services for the internal mechanisms of rolls used on paper-making machines; and manufactures a nd repairs spreader rolls. The company markets its products through its direct sales force under Huyck Wangner, Weavexx, Stowe Woodward, Mount Hope, Robec, and Xibe brand names. Xerium Technologies, Inc. was founded in 1999 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Xerium Technologies (NYSE: XRM ) , whose recent revenue and earnings are plotted below. - [By Roberto Pedone]
One cyclical consumer goods player that's starting to trend within range of triggering a near-term breakout trade is Xerium Technologies (XRM), a manufacturer and supplier of two types of consumable products, clothing and roll covers, used mainly in the production of paper. This stock has been on fire so far in 2013, with shares up sharply by 313%.
If you take a look at the chart for Xerium Technologies, you'll notice that this stock has been uptrending strong for the last two months and change, with shares moving higher from its low of $9.94 to its recent high of $12.97 a share. During that uptrend, shares of XRM have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of XRM within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in XRM if it manages to break out above some near-term overhead resistance at $12.97 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 100,685 shares. If that breakout triggers soon, then XRM will set up to re-test or possibly take out its 52-week high at $14.04 a share. Any high-volume move above that level will then give XRM a chance to tag its next major overhead resistance levels at $18 to $20 a share.
Traders can look to buy XRM off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12.28, or near its 50-day at $11.35 a share. One can also buy XRM off strength once it takes out $12.97 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top Up And Coming Stocks To Buy For 2014: Natural Grocers By Vitamin Cottage Inc (NGVC)
Natural Grocers by Vitamin Cottage, Inc., incorporated on April 9, 2012, is a specialty retailer of natural and organic groceries and dietary supplements. The Company operates within the natural products retail industry. The Company offers products and brands, including a selection of natural and organic food, dietary supplements, body care products, pet care products and books.
The Company offers its customers an average of approximately 18,000 store-keeping units (SKUs) of natural and organic products per store, including an average of approximately 7,000 SKU of dietary supplements. As of June 30, 2012, the Company operated 55 stores in 11 states, including Colorado, Idaho, Kansas, Missouri, Montana, Nebraska, New Mexico, Oklahoma, Texas, Utah and Wyoming, as well as a bulk food repackaging facility and distribution center in Colorado. The size of its stores varies from 5,000 selling square feet to 14,500 selling square feet, and a new store averages 9,500 selling square feet.
Advisors' Opinion:- [By David Mamos]
The Fresh Market Inc. (Nasdaq: TFM), Natural Grocers by Vitamin Cottage Inc. (NYSE: NGVC), and privately held Trader Joe's are others crowding into the field.
No comments:
Post a Comment